Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry B Koon

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Oncology|March 7, 2014
What is the role of chemotherapy in the treatment of melanoma?Ahmed I Megahed, Henry B Koon
Expert Review of Anticancer Therapy|December 26, 2006
Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistanceHenry B Koon, Michael B Atkins
Current Opinion in Oncology|August 9, 2006
Signal transduction targets in Kaposi's sarcomaRyan Sullivan, Bruce J Dezube, Henry B Koon
Journal of Cellular Physiology|September 27, 2006
Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational scienceBruce J Dezube, Ryan Sullivan, Henry B Koon
Expert Opinion on Therapeutic Targets|July 7, 2007
FOXP1: a potential therapeutic target in cancerHenry B Koon, Gregory C Ippolito, Alison H Banham, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 30, 2014
Current systemic therapies for melanomaDarren M Palathinkal, Timmie R Sharma, Henry B Koon, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Evolving impact of long-term survival results on metastatic melanoma treatmentOlivier Michielin, Michael B Atkins, Henry B Koon, et al.
Peptides|December 17, 2009
Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor betaHameem I Kawsar, Santosh K Ghosh, Stanley A Hirsch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancerHans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cellsHans J J van der Vliet, Ruojie Wang, Simon C Yue, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|March 7, 2014
What is the role of chemotherapy in the treatment of melanoma?Ahmed I Megahed, Henry B Koon
Expert Review of Anticancer Therapy|December 26, 2006
Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistanceHenry B Koon, Michael B Atkins
Current Opinion in Oncology|August 9, 2006
Signal transduction targets in Kaposi's sarcomaRyan Sullivan, Bruce J Dezube, Henry B Koon
Journal of Cellular Physiology|September 27, 2006
Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational scienceBruce J Dezube, Ryan Sullivan, Henry B Koon
Expert Opinion on Therapeutic Targets|July 7, 2007
FOXP1: a potential therapeutic target in cancerHenry B Koon, Gregory C Ippolito, Alison H Banham, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 30, 2014
Current systemic therapies for melanomaDarren M Palathinkal, Timmie R Sharma, Henry B Koon, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Evolving impact of long-term survival results on metastatic melanoma treatmentOlivier Michielin, Michael B Atkins, Henry B Koon, et al.
Peptides|December 17, 2009
Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor betaHameem I Kawsar, Santosh K Ghosh, Stanley A Hirsch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancerHans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cellsHans J J van der Vliet, Ruojie Wang, Simon C Yue, et al.
Pageof 3